Meditation technique brings peace of mind to breast cancer survivors

Share this article:

An intervention known as mindfulness-based stress reduction (MBSR) showed a trend toward improving psychological outcomes by reducing mood disturbance in women who had survived early-stage breast cancer.

MBSR incorporates meditation, yoga, and physical awareness. In a recent study reported in the Western Journal of Nursing Research (2011;33(8):993-995), nurse researchers at the University of Missouri–Columbia (MU) administered MBSR group sessions over a period of 8 to 10 weeks. During these sessions, the breast cancer survivors practiced meditation skills, discussed how bodies respond to stress, and learned coping techniques.

Compared with a control group that received no MBSR training, participants who learned MBSR experienced statistically significant reductions in blood pressure, heart rate, and respiratory rate; increased their mindfulness state, and experienced improvements in mood.

Although the effects of MBSR on reducing stress were statistically significant on the physiological outcome (morning cortisol) at the measurement after the intervention completion, this effect was not sustained at 1-month follow-up. Coinvestigator and MU professor of nursing Jane Armer recommended in a separate statement that patients practice mindfulness-based meditation every day or at least routinely to garner short- and long-term benefits.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Survival equivalent with cetuximab or bevacizumab in metastatic colorectal cancer

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.

Some aggressive cancers may respond to anti-inflammatory drugs

New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs currently used to treat rheumatoid arthritis.

Pain and itch may indicate skin cancer

Pain and itch may indicate skin cancer

Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study.